Prince Akwasi Mensah

Array ( [id] => 6716455 [patent_doc_number] => 20030027803 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-06 [patent_title] => 'Method and composition for inhibiting the incidence and proliferation of nervous system and brain cancer cells' [patent_app_type] => new [patent_app_number] => 09/777559 [patent_app_country] => US [patent_app_date] => 2001-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 5909 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20030027803.pdf [firstpage_image] =>[orig_patent_app_number] => 09777559 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5829207 [patent_doc_number] => 20020068724 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-06 [patent_title] => 'Method and composition of novel compounds for the therapy and targeting of the primary modalities of cancer cell proliferation and homeostasis' [patent_app_type] => new [patent_app_number] => 09/777151 [patent_app_country] => US [patent_app_date] => 2001-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 2814 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20020068724.pdf [firstpage_image] =>[orig_patent_app_number] => 09777151 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6908370 [patent_doc_number] => 20010011137 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-08-02 [patent_title] => 'Use of triphenylmethyl-1,2,3-triazoles' [patent_app_type] => new [patent_app_number] => 09/774144 [patent_app_country] => US [patent_app_date] => 2001-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2155 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0011/20010011137.pdf [firstpage_image] =>[orig_patent_app_number] => 09774144 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1490790 [patent_doc_number] => 06417206 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-09 [patent_title] => 'Antitussive/antihist aminic/decongestant compositions' [patent_app_type] => B1 [patent_app_number] => 09/771130 [patent_app_country] => US [patent_app_date] => 2001-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1393 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/417/06417206.pdf [firstpage_image] =>[orig_patent_app_number] => 09771130 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5908213 [patent_doc_number] => 20020143031 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-03 [patent_title] => 'Treatment of cardiovascular disease with quinolinone enantiomers' [patent_app_type] => new [patent_app_number] => 09/771104 [patent_app_country] => US [patent_app_date] => 2001-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10257 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20020143031.pdf [firstpage_image] =>[orig_patent_app_number] => 09771104 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6818307 [patent_doc_number] => 20030069265 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-10 [patent_title] => 'Therapeutics for chemokine mediated diseases' [patent_app_type] => new [patent_app_number] => 09/767378 [patent_app_country] => US [patent_app_date] => 2001-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 8864 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20030069265.pdf [firstpage_image] =>[orig_patent_app_number] => 09767378 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 935483 [patent_doc_number] => 06974833 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-12-13 [patent_title] => 'Synergistic compositions comprising ascobate and lysine for states related to extra cellular matrix degeneration' [patent_app_type] => utility [patent_app_number] => 09/761395 [patent_app_country] => US [patent_app_date] => 2001-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3188 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 159 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/974/06974833.pdf [firstpage_image] =>[orig_patent_app_number] => 09761395 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1417222 [patent_doc_number] => 06512009 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-01-28 [patent_title] => 'Combination for the treatment of alcohol and drug dependence containing an opioid antagonist and a NMDA receptor complex modulator' [patent_app_type] => B1 [patent_app_number] => 09/647091 [patent_app_country] => US [patent_app_date] => 2001-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1829 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/512/06512009.pdf [firstpage_image] =>[orig_patent_app_number] => 09647091 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6805457 [patent_doc_number] => 20030232851 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-18 [patent_title] => 'Viral treatment' [patent_app_type] => new [patent_app_number] => 09/758853 [patent_app_country] => US [patent_app_date] => 2001-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11356 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20030232851.pdf [firstpage_image] =>[orig_patent_app_number] => 09758853 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4269942 [patent_doc_number] => 06306910 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-23 [patent_title] => 'Use of Gaba-analogues for treating insomnia' [patent_app_type] => 1 [patent_app_number] => 9/743370 [patent_app_country] => US [patent_app_date] => 2001-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1810 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/306/06306910.pdf [firstpage_image] =>[orig_patent_app_number] => 743370 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1459955 [patent_doc_number] => 06391868 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-21 [patent_title] => 'Use of 5-alpha-androst-1-en-3,17-dione to increase the level of the anabolic/androgenic hormone 17-beta-hydroxy-5-alpha-androst-1-en-3-one in humans' [patent_app_type] => B1 [patent_app_number] => 09/756542 [patent_app_country] => US [patent_app_date] => 2001-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1216 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/391/06391868.pdf [firstpage_image] =>[orig_patent_app_number] => 09756542 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7015234 [patent_doc_number] => 20010051652 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-12-13 [patent_title] => 'Method of treating paralysis of the extremities caused by cerebral infarction' [patent_app_type] => new [patent_app_number] => 09/754312 [patent_app_country] => US [patent_app_date] => 2001-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3899 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0051/20010051652.pdf [firstpage_image] =>[orig_patent_app_number] => 09754312 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1291456 [patent_doc_number] => 06630449 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-10-07 [patent_title] => 'Method for reducing the effect of nicotine addiction and dependancy' [patent_app_type] => B2 [patent_app_number] => 09/748647 [patent_app_country] => US [patent_app_date] => 2000-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3186 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/630/06630449.pdf [firstpage_image] =>[orig_patent_app_number] => 09748647 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1231843 [patent_doc_number] => 06693132 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-02-17 [patent_title] => 'Methods for using alkanoyloxymethyl esters' [patent_app_type] => B2 [patent_app_number] => 09/742729 [patent_app_country] => US [patent_app_date] => 2000-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4202 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/693/06693132.pdf [firstpage_image] =>[orig_patent_app_number] => 09742729 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6875692 [patent_doc_number] => 20010000786 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-05-03 [patent_title] => 'Product for promoting weight loss in overweight dogs' [patent_app_type] => new-utility [patent_app_number] => 09/738492 [patent_app_country] => US [patent_app_date] => 2000-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 3787 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0000/20010000786.pdf [firstpage_image] =>[orig_patent_app_number] => 09738492 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7040818 [patent_doc_number] => 20010005502 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-06-28 [patent_title] => 'Monofluoro phosphorylated macromolecules' [patent_app_type] => new-utility [patent_app_number] => 09/737684 [patent_app_country] => US [patent_app_date] => 2000-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3388 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0005/20010005502.pdf [firstpage_image] =>[orig_patent_app_number] => 09737684 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1570644 [patent_doc_number] => 06498193 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-12-24 [patent_title] => 'Treatment for complications of type 2 diabetes' [patent_app_type] => B2 [patent_app_number] => 09/735683 [patent_app_country] => US [patent_app_date] => 2000-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2062 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/498/06498193.pdf [firstpage_image] =>[orig_patent_app_number] => 09735683 [rel_patent_id] =>[rel_patent_doc_number] =>)